- Cliff Equity
- Posts
- 📈 Is Tesla’s Cybercab a Game-Changer or Gimmick?
📈 Is Tesla’s Cybercab a Game-Changer or Gimmick?
GSK Coughs Up Billions in Zantac Row
This is Cliff Equity, the UK’s business newsletter that keeps you informed on what’s important in tech, business and finance in less than 5 minutes
In today’s stories:
Is Tesla’s Cybercab a Game-Changer or Gimmick?
GSK Coughs Up Billions in Zantac Row
Hippo Coin Rides Waves to £7.5 Million!
The summary: Elon Musk’s long-awaited Cybercab reveal promises to be either a thrilling leap into the future of self-driving taxis or yet another ambitious Tesla concept that’s slow off the starting line!
The details:
Elon Musk is set to finally reveal Tesla’s long-awaited Cybercab robotaxi, but after delays and secrecy, he’s under pressure to deliver more than just butterfly doors and bold promises.
Musk claims last-minute tweaks caused the delays, but analysts expect Thursday’s “We, Robot” event to clarify if this futuristic cab is more than just a concept with cool wings.
Scant details about the Cybercab have surfaced, but the buzz suggests it could reshape ridesharing—if it works as promised, of course.
With rivals like Waymo speeding ahead, some wonder if Tesla should focus on affordable EVs rather than sci-fi robotaxis.
Why it matters: Elon Musk’s Cybercab could either be Tesla’s next leap into sci-fi reality or just another stalled dream. With competition from Waymo heating up and Tesla execs slipping away, it’s high time Musk proves his vision isn’t all talk and butterfly wings. Otherwise, he might find himself in the slow lane of the self-driving race.
The summary: GSK’s $2.2 billion settlement over Zantac lawsuits marks a huge step towards putting the heartburn drug’s legal woes to bed, but with more trials looming, the drama isn’t over yet!
The details:
GSK coughs up a potential $2.2 billion to settle 80,000 lawsuits, all claiming Zantac, the former heartburn hero, caused cancer.
GSK insists there's "no reliable evidence" linking Zantac's active ingredient to cancer but settles anyway, avoiding years of courtroom drama.
Zantac, once the toast of the pharmaceutical world, fell from grace in 2020 after the FDA flagged its active ingredient for turning carcinogenic under heat.
Pfizer and Sanofi have also paid up, while Boehringer Ingelheim digs in for a California showdown. Meanwhile, Delaware courts brace for the next round of Zantac trials.
Why it matters: GSK's hefty payout is a stark reminder that even pharma giants can't escape their past, especially when cancer lawsuits come knocking. With tens of thousands of claims in the rearview mirror, investors will breathe a little easier, but the legal vultures circling Boehringer Ingelheim are still hungry. The Zantac saga also raises awkward questions about how well pharma watchdogs are guarding the henhouse.
The summary: In a delightful twist of fate, the cheeky Moodeng cryptocurrency, inspired by a viral baby hippo, has transformed meme-loving investors into millionaires overnight, proving that in the unpredictable world of crypto, anything can happen—especially when a cute critter is involved!
The details:
A fringe cryptocurrency called Moodeng, inspired by a viral baby hippo, has skyrocketed by nearly a million per cent, turning one lucky trader’s £800 into a casual £7.5 million. Hippos and crypto—who knew?
Investors are calling it “meme season,” with other viral coins like Popcat joining the party. Traders are even talking about a "memecoin supercycle." Is this finance or the internet’s fever dream?
After a dip, Moodeng rallied again, thanks to Ethereum co-founder Vitalik Buterin selling off 10 billion tokens and donating the proceeds to charity. Turns out memecoins can be charitable too.
The overall crypto market has stayed steady, but Moodeng and friends prove that the world of digital coins is still as unpredictable as ever. Meanwhile, Dogecoin remains the elder statesman of memecoins, quietly sitting at $0.10.
Why it matters: The wild ride of Moodeng shows just how whimsical the world of cryptocurrencies can be, turning a cute hippo into a financial phenomenon faster than you can say "financial fad." With investors now chasing meme coins like it’s the latest trend in TikTok dances, it’s a reminder that the crypto market can be both lucrative and utterly bonkers. Meanwhile, Dogecoin sits comfortably like an old dog at the pub—still relevant, but clearly not as eager to chase the latest shiny object.
Trending stories
How would you rate today's edition: |